凯杰生物 QGEN
$50.33 −$0.53 (-1.04%)
休市 · Nov 7, 9:50 pm ET · 最新盘后价 $50.40 +0.14%
开盘$50.42
昨收$50.86
当日区间$50.26 – $50.50
成交量3.39M
市值$10.39B
市盈率(TTM)27.7
股息率0.70%
股权结构与仓位
谁在持有、谁在做空,以及大资金的流向
机构持股比例75.7%-6.05 个百分点,较上季度
持仓机构数537+1 ,较上季度
内部人近期交易0次买入 / 5次卖出净卖出
空头持仓比例3.49% 占流通股回补天数 3.3 · 截至 15 Oct 2026
卖空成交量占比20.5%近5日成交量平均占比
卖空成交量占当日成交量比例
大单净流入,近20个交易日
大单买入减卖出的净额(美元)。该窗口期内:−$222.50M(6个净流入日,14个净流出日)。
按单量净流入,近20个交易日
超大单/大单近似机构级别交易;中单/小单近似散户级别交易。各档买入减卖出净额,按窗口期累计。
已披露的前五大股东合计持有23.6%的流通股。
最大股东
按投资者类型
过去6次双周报告中(31 Jul 2026至15 Oct 2026),空头持仓占流通股比例已从3.99%降至3.49%。
近期机构持仓变动
| 股东 | 类型 | 期间 | 持股变动 | 新持股比例 |
|---|---|---|---|---|
| Merrill Lynch, Pierce, Fenner & Smith Incorporated | Private Company | 2026/Q3 | +2,100,449 | 1.2% |
| Bank of America Corporation | Public Company | 2026/Q3 | +1,457,047 | 1.5% |
| Merrill Lynch, Pierce, Fenner & Smith Incorporated | Private Company | 2026/Q3 | +1,616,499 | 1.0% |
| Bank of America Corporation | Public Company | 2026/Q3 | +1,192,561 | 1.3% |
| Nuveen Asset Management LLC | Insurance Company | 2026/Q3 | +654,260 | 0.4% |
| Barclays PLC | Public Company | 2026/Q3 | +2,788,237 | 1.6% |
| UBS Asset Management | Mutual Fund | 2026/Q3 | +1,930,454 | 2.6% |
| Principal Global Investors, LLC | Mutual Fund | 2026/Q3 | +6,643,158 | 3.2% |
| Marshall Wace LLP | Hedge Fund | 2026/Q3 | +2,701,482 | 1.7% |
| Dimensional Fund Advisors | Mutual Fund | 2026/Q3 | +1,091,708 | 1.3% |
| Point72 Asset Management, L.P. | Hedge Fund | 2026/Q3 | +1,076,933 | 0.8% |
| Sone Capital Management, LLC | Hedge Fund | 2026/Q3 | +851,611 | 0.4% |
| Morgan Stanley | Public Company | 2026/Q3 | +733,334 | 2.0% |
| EARNEST Partners, LLC | Mutual Fund | 2026/Q3 | +704,966 | 2.2% |
| Freestone Grove Partners LP | Hedge Fund | 2026/Q3 | +649,865 | 0.6% |
按报告期列出的机构买卖动态,变动幅度从大到小排列。
内部人交易
| 日期 | 内部人 | 职位 | 交易类型 | 股数 | 价格 | 交易后持股 |
|---|---|---|---|---|---|---|
| 14 Aug 2025 | Roland Sackers | CFO, MD & Member of Management Board | Intent to Sell (Form 144) | -29,851 | $51.80 | – |
| 14 Aug 2025 | Thierry Bernard | Former CEO, MD & Member of Management Board | Intent to Sell (Form 144) | -23,750 | $51.37 | – |
| 13 Aug 2025 | Roland Sackers | CFO, MD & Member of Management Board | Intent to Sell (Form 144) | -17,648 | $51.58 | – |
| 12 Aug 2025 | Roland Sackers | CFO, MD & Member of Management Board | Intent to Sell (Form 144) | -47,500 | $51.71 | – |
| 10 Sep 2024 | Roland Sackers | CFO, MD & Member of Management Board | Intent to Sell (Form 144) | -23,090 | $49.80 | – |
数据来自Form 4/Form 144申报文件。负数为减持(出售、赠予或代扣税款股份),正数为增持。
空头持仓(按报告期)
| 报告日期 | 空头股数 | 占流通股比例 | 回补天数 |
|---|---|---|---|
| 15 Oct 2026 | 7,202,427 | 3.5% | 3.3 |
| 30 Sep 2026 | 7,682,054 | 3.7% | 3.6 |
| 15 Sep 2026 | 7,664,091 | 3.7% | 4.5 |
| 31 Aug 2026 | 7,509,104 | 3.6% | 2.2 |
| 14 Aug 2026 | 10,140,064 | 4.9% | 3.1 |
| 31 Jul 2026 | 8,232,939 | 4.0% | 4.0 |
暂无评论——快来第一个聊聊 QGEN。
登录后参与讨论。